01Stereotactic Radiosurgery (CyberKnife)
CyberKnife M6 robotic radiosurgery system in the treatment room — Foshan Fosun Chancheng Hospital. Source 1.
- No incision
- No anesthesia (most cases)
- 1–5 sessions
- Outpatient · 15–30 min
30-second answer:
CyberKnife is a robotic "knife that doesn't cut." It destroys tumors with concentrated radiation tracked in real time — no scalpel, no hospital stay, and most patients finish in one to five painless outpatient visits.
What it is
A form of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) that delivers a tumor-destroying radiation dose with sub-millimeter precision. Unlike a Gamma Knife, CyberKnife needs no rigid head frame — it is frameless and image-guided.
How it works
A robotic arm moves around you and delivers hundreds of narrow radiation beams that converge on the tumor from many angles.
The system tracks the tumor as you breathe, keeping the beam locked on target. This is particularly important for tumors in the lung, liver, and pancreas.
Our Foshan hospital operates the 6th-generation CyberKnife M6, installed in June 2022 — among only four in South China. The team is led by Dr. Yang Jun.
Radiation oncologists and physicists plan each case; the team is led by Dr. Yang Jun, co-author of international CyberKnife quality-control standards.
What to expect
Each session lasts roughly 15–30 minutes, with typical treatment courses consisting of 1–5 sessions.
No incision is required and, in most cases, no anesthesia is needed. Many patients can return to their normal activities on the same day.
No hospital admission is required for the treatment itself.
You will have follow-up imaging on a schedule to confirm tumor response.
Often used for
Brain: meningioma, pituitary adenoma, acoustic neuroma, arteriovenous malformation (AVM), brain metastases, trigeminal neuralgia.
Body: lung cancer and lung metastases, liver cancer, pancreatic cancer, prostate cancer, spinal and bone metastases.
Not every tumor is suitable for radiosurgery. Tumor size, location, and previous radiation treatment all need to be considered. A review of your imaging will help determine whether radiosurgery may be appropriate for your case.
Evidence & Track Record
- →The Foshan Center reports ~1,000 radiosurgery cases completed since the M6 was installed in June 2022, based on hospital-published figures through March 2026.
- →The center's team, including Chief Radiation Oncologist Prof. Wang Enmin, who holds China's first doctoral degree in Gamma Knife radiosurgery, has performed more than 10,000 radiosurgery cases.
- →The center was the first institutional member in Asia of the International Radiosurgery Society (RSS). Its 2022 Best Paper Award recognized the team's SCART technique for ultra-large, recurrent, and refractory tumors.
- →The center's protocols follow international standards and are subject to regular international quality audits.